1. Home
  2. GNLN vs PPBT Comparison

GNLN vs PPBT Comparison

Compare GNLN & PPBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Greenlane Holdings Inc.

GNLN

Greenlane Holdings Inc.

N/A

Current Price

$3.28

Market Cap

3.3M

ML Signal

N/A

Logo Purple Biotech Ltd.

PPBT

Purple Biotech Ltd.

HOLD

Current Price

$1.58

Market Cap

2.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GNLN
PPBT
Founded
2005
2010
Country
United States
Israel
Employees
N/A
N/A
Industry
Durable Goods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3M
2.9M
IPO Year
2019
2014

Fundamental Metrics

Financial Performance
Metric
GNLN
PPBT
Price
$3.28
$1.58
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$30.00
AVG Volume (30 Days)
11.5K
113.4K
Earning Date
05-14-2026
05-20-2026
Dividend Yield
N/A
N/A
EPS Growth
21.57
N/A
EPS
N/A
N/A
Revenue
$13,275,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.01
$0.41
52 Week High
$7.73
$5.18

Technical Indicators

Market Signals
Indicator
GNLN
PPBT
Relative Strength Index (RSI) 47.95 23.62
Support Level $2.71 $0.57
Resistance Level $3.50 $3.09
Average True Range (ATR) 0.18 0.25
MACD -0.02 -0.10
Stochastic Oscillator 71.15 11.98

Price Performance

Historical Comparison
GNLN
PPBT

About GNLN Greenlane Holdings Inc.

Greenlane Holdings Inc is a platform for the development and distribution of premium cannabis accessories, vape devices, and lifestyle products. It provides a wide array of consumer ancillary products and industrial ancillary products to thousands of cannabis producers, processors, brands, and retailers (Cannabis Operators). It serves specialty retailers, smoke shops, head shops, convenience stores, and consumers. Geographically, it operates in United States, Canada, and Europe. It derives majority revenue from the United States. Its two operating segments are: Wholesale and Distribution, which includes legacy e-commerce and drop-ship operations; and Digital Assets, which includes digital asset treasury activities including acquisition, staking and validator participation related to BERA.

About PPBT Purple Biotech Ltd.

Purple Biotech Ltd is a clinical-stage biotechnology company focused on the development and commercialization of pharmaceuticals. It currently have a preclinical tri-specific antibodies platform, CAPTN-3, with its therapeutic candidates, IM1240 and IM1305, and two other oncology therapeutic candidates that are in the clinical trial phase, CM24 and NT219, neither of which has been approved for marketing and are not being sold, marketed, or commercialized.

Share on Social Networks: